Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Shalini Pereira"'
Autor:
Heidi J. Gray, Payel Chatterjee, Rachele Rosati, Lauren R. Appleyard, Grace J. Durenberger, Robert L. Diaz, Hallie A. Swan, Danielle Peretti, Maddy Pollastro, Trevor Ainge, Katannya Kapeli, Shalini Pereira, Astrid L. Margossian, Kalyan Banda, Barbara A. Goff, Elizabeth M. Swisher, Brady Bernard, Christopher J. Kemp, Carla Grandori
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-6 (2023)
Abstract Low-grade serous ovarian cancer (LGSOC) typically responds poorly to standard platinum-based chemotherapy and new therapeutic approaches are needed. We describe a remarkable response to targeted therapy in a patient with platinum-resistant,
Externí odkaz:
https://doaj.org/article/8a9cc59b3ce64630836df3b6b10cdaf8
Autor:
Marwah Al-Aloosi, Amanda M. Prechtl, Payel Chatterjee, Brady Bernard, Christopher J. Kemp, Rachele Rosati, Robert L. Diaz, Lauren R. Appleyard, Shalini Pereira, Alex Rajewski, Amber McDonald, Eva J. Gordon, Carla Grandori
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
Patients presenting with stage 4 ovarian carcinoma, including low-grade serous disease, have a poor prognosis. Although platinum-based therapies can offer some response, these therapies are associated with many side effects, and treatment resistance
Externí odkaz:
https://doaj.org/article/fcc76ebb292445b4b3f929be800bb6b7
Autor:
Susan L. Woods, Robert G. Ramsay, Daniel L. Worthley, Alexander G. Heriot, Carla Grandori, Siddhartha Mukherjee, Jeanne Tie, Michael Michael, G. Adam Whitney, Shalini Pereira, Michael P. Flood, Peter J. Hewett, Julie Marker, Gayle X.Y. Tye, Timothy Price, Hiroki Kobayashi, Anne B. Richardson, Laura Vrbanac, Tamsin R.M. Lannagan, Rachele Rosati, Tongtong Wang, Michael Churchill, Josephine A. Wright, Vignesh Narasimhan
Peritonoid sensitivity to standard care chemotherapeutic regimens ex vivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1914dfdc5ce1aab3efb5b75c924e721a
https://doi.org/10.1158/1078-0432.22475003.v1
https://doi.org/10.1158/1078-0432.22475003.v1
Autor:
Susan L. Woods, Robert G. Ramsay, Daniel L. Worthley, Alexander G. Heriot, Carla Grandori, Siddhartha Mukherjee, Jeanne Tie, Michael Michael, G. Adam Whitney, Shalini Pereira, Michael P. Flood, Peter J. Hewett, Julie Marker, Gayle X.Y. Tye, Timothy Price, Hiroki Kobayashi, Anne B. Richardson, Laura Vrbanac, Tamsin R.M. Lannagan, Rachele Rosati, Tongtong Wang, Michael Churchill, Josephine A. Wright, Vignesh Narasimhan
Purpose:Patients with colorectal cancer with peritoneal metastases (CRPMs) have limited treatment options and the lowest colorectal cancer survival rates. We aimed to determine whether organoid testing could help guide precision treatment for patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf344d1fef46cf1196a4ad616bf9fb0
https://doi.org/10.1158/1078-0432.c.6528956
https://doi.org/10.1158/1078-0432.c.6528956
Autor:
Susan L. Woods, Robert G. Ramsay, Daniel L. Worthley, Alexander G. Heriot, Carla Grandori, Siddhartha Mukherjee, Jeanne Tie, Michael Michael, G. Adam Whitney, Shalini Pereira, Michael P. Flood, Peter J. Hewett, Julie Marker, Gayle X.Y. Tye, Timothy Price, Hiroki Kobayashi, Anne B. Richardson, Laura Vrbanac, Tamsin R.M. Lannagan, Rachele Rosati, Tongtong Wang, Michael Churchill, Josephine A. Wright, Vignesh Narasimhan
Summary of drug panels and peritonoid genomic information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ef1e96e0673e6c1da4687fd57bca6f
https://doi.org/10.1158/1078-0432.22474994.v1
https://doi.org/10.1158/1078-0432.22474994.v1
Autor:
Susan L. Woods, Robert G. Ramsay, Daniel L. Worthley, Alexander G. Heriot, Carla Grandori, Siddhartha Mukherjee, Jeanne Tie, Michael Michael, G. Adam Whitney, Shalini Pereira, Michael P. Flood, Peter J. Hewett, Julie Marker, Gayle X.Y. Tye, Timothy Price, Hiroki Kobayashi, Anne B. Richardson, Laura Vrbanac, Tamsin R.M. Lannagan, Rachele Rosati, Tongtong Wang, Michael Churchill, Josephine A. Wright, Vignesh Narasimhan
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e24923a7ea1552a193fc96d68ad7a3f
https://doi.org/10.1158/1078-0432.22474997.v1
https://doi.org/10.1158/1078-0432.22474997.v1
Autor:
Anajane G. Smith, Chul Woo Pyo, Shalini Pereira, Scott T. Stoll, Ahmed A. Mostafa, Amanda Willis, Daniel E. Geraghty, Noureddine Berka, Crystal Y. Usenko, Faisal M. Khan, Marcelo J. Pando, Andrés Jaramillo, Maria Bettinotti, Wyatt C. Nelson, Medhat Askar
Publikováno v:
Hla
Many clinical laboratories supporting solid organ transplant programs use multiple HLA genotyping technologies, depending on individual laboratory needs. Sequence‐specific primers and quantitative polymerase chain reaction (qPCR) serve the rapid tu
Autor:
Rachele Rosati, G. Adam Whitney, Michael Flood, Vignesh Narasimhan, Susan L. Woods, Josephine A. Wright, Peter J. Hewett, Tongtong Wang, Michael Churchill, Tamsin R M Lannagan, Laura Vrbanac, Timothy J. Price, Siddhartha Mukherjee, Julie Marker, Anne B Richardson, Daniel L. Worthley, Jeanne Tie, Gayle X Y Tye, Shalini Pereira, Alexander G. Heriot, Michael Michael, Hiroki Kobayashi, Carla Grandori, Robert G. Ramsay
Publikováno v:
Clin Cancer Res
Purpose: Patients with colorectal cancer with peritoneal metastases (CRPMs) have limited treatment options and the lowest colorectal cancer survival rates. We aimed to determine whether organoid testing could help guide precision treatment for patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25cde22999407c6031802dcf47768099
https://europepmc.org/articles/PMC8366292/
https://europepmc.org/articles/PMC8366292/
Autor:
Geoffrey Neale, Kelly A. Andrews, Xiaodian Sun, Daniel E. Geraghty, Asha Pillai, Shalini Pereira, Paige Tedrick, Anouk A.J. Hamers, Kim E. Nichols, Katherine Verbist
Publikováno v:
Cytotherapy
Background aims Key obstacles in human iNKT cell translational research and immunotherapy include the lack of robust protocols for dependable expansion of human iNKT cells and the paucity of data on phenotypes in post-expanded cells. Methods We delin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d987de827b6ef67310f6220b2bfab42
https://europepmc.org/articles/PMC7666372/
https://europepmc.org/articles/PMC7666372/
Autor:
Madison Pollastro, Kalyan Banda, Barbara A. Goff, Hallie A. Swan, Shalini Pereira, Christopher J. Kemp, Danielle Peretti, Payel Chatterjee, Astrid Margossian, Vijayakrishna K. Gadi, Grace Durenberger, Elizabeth M. Swisher, Carla Grandori, G. Adam Whitney, William P. Harris, Adam Diehl, Mia Lints, Annie Richardson, Lauren Appleyard, Rachele Rosati
Publikováno v:
Journal of Clinical Oncology. 39:2602-2602
2602 Background: A CLIA-certified organoid based drug sensitivity assay (a cancer organogram) has been developed for all solid tumors. An actionable report of organogram sensitivities to endocrine, chemotherapy and targeted agents, produced a drug se